Characteristic | Data |
---|---|
Patients | 53 (100%) |
Women | 31 (58%) |
Age (y) | 65 (13) |
PET/CT indication | |
Suspicion of SiNETs | 15 (28%) |
Staging of histologically proven metastatic SiNETs | 38 (72%) |
World Health Organization grade, 2019 | |
1 | 23 (43%) |
2 | 25 (47%) |
3 | 3 (6%) |
Ki-67 | 5.8 (8.7) (median, 3.7) |
Biochemical tumor markers | |
Elevated serum CgA | 28 (53%) |
Elevated 24-h urinary 5-HIAA | 14 (26%) |
Long-acting somatostatin analogs | 13 (25%) |
Qualitative data are number and percentage; continuous data are median and SD.